Drugs & Pharmaceuticals

Does it make any sense to use an antibiotic like this?

Pricing a new drug is not an easy task, Gilead who is producing remdesivir is no stranger to pricing controversy, the release of Solvaldi, their drug to cure Hepatitis C, had a list price of $84,000 for a full treatment course.

Those who cannot remember the past are condemned to repeat it. (George Santayana). Never let a good crisis go to waste. (Churchill? Emanuel?).

What a letdown.

Six weeks of endless speculation, guessing, second-guessing, ups, and downs about whether the world would have its first effective coronavirus drug has been exhausting. I see the damn molecule in my sleep.

First, we do not know whether remdesivir has failed. Not by a long shot. The leaked draft document of a trial in China may or may not be real.

The world got a taste, albeit, a premature taste, of some bad news this afternoon.

Gilead Science is the Tom Brady of the antiviral research world. No other company even comes close.

The first discussion of the disease that would later become AIDS appeared in an article in the June 5, 1981 Morbidity and Mortality Weekly Report (MMWR).

Last week, Tom Frieden, the former Director of the US Centers for Disease Control in the Obama administration, wrote an editorial in the